| Application no. and date | 10789873.6 (espacenet) (Federated) (European Patent Register), 20100618 | | Patent/reg. no. and date | DK/EP 2442651, 20150729 | | Publication date | 20120425 | | Priority no. and date | US 269070 P, 20090619 | | EP pub. no. and date |
EP 2442651 20120425 | | Effective date | | | Applicant/owner | Teva Pharmaceutical Industries Ltd., 5 Basel Street
P.O. Box 3190
49131 Petah Tiqva, IL | | Applicant ref. no. | P56804DK01 | | Inventor | TARCIC, Nora, Migdal David 29/1
Modiin, IL,
BAR-ZOHAR, Dan, 10 Havazelet Street
52365 Ramat-Gan, IL,
KOFLER, Dina, Hadafna 24
Kadima-Zoran, IL | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A01N 43/42 (2006.01) , A61K 31/136 (2006.01) , A61K 31/4704 (2006.01) , A61K 38/16 (2006.01) , A61K 45/06 (2006.01) , A61P 25/00 (2006.01) | | Title | BEHANDLING AF MULTIPEL SKLEROSE MED LAQUINIMOD | | Int. application no. | US2010001759 | | Int. publication no. | WO2010147665 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
